Literature DB >> 25637017

ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages.

Magdalena Herová1, Mattia Schmid1, Claudio Gemperle1, Martin Hersberger2.   

Abstract

ChemR23 is a G protein-coupled receptor that is triggered by two ligands, the peptide chemerin and the eicosapentaenoic acid-derived lipid mediator resolvin E1 (RvE1). Chemerin acts as a chemoattractant for monocytes and macrophages, whereas RvE1 promotes resolution of inflammation-inducing macrophage phagocytosis of apoptotic neutrophils. Although ChemR23-mediated signaling plays a role in mononuclear cell migration to inflamed tissue, as well as in the resolution of inflammation, its regulation in different polarization states of macrophages is largely unknown. We analyzed the expression and function of ChemR23 in monocytes and differently activated human primary macrophages. Using 5' RACE, we identified three transcription start sites and several splice variants of ChemR23 in both monocytes and macrophages. Although the promoters P1 and P3 are used equally in unpolarized macrophages, stimulation with LPS or IFN-γ leads to increased transcription from P3 in inflammatory M1 macrophages. Such ChemR23-expressing M1 macrophages are chemotactic to chemerin, whereas M2 macrophages not expressing ChemR23 surface receptor are not. Repolarization of ChemR23-expressing M1 macrophages with 10 nM RvE1 increases IL-10 transcription and phagocytosis of microbial particles, leading to a resolution-type macrophage distinct from the M2 phenotype. These results show that ChemR23 is tightly regulated in response to inflammatory and anti-inflammatory stimuli. The restricted expression of ChemR23 in naive and M1 macrophages supports the role of ChemR23 in the attraction of macrophages to inflamed tissue by chemerin and in the initiation of resolution of inflammation through RvE1-mediated repolarization of human M1 macrophages toward resolution-type macrophages.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25637017     DOI: 10.4049/jimmunol.1402166

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro.

Authors:  Aimeé Salas-Hernández; Claudio Espinoza-Pérez; Raúl Vivar; Jenaro Espitia-Corredor; José Lillo; Pablo Parra-Flores; Carlos F Sánchez-Ferrer; Concepción Peiró; Guillermo Díaz-Araya
Journal:  Mol Biol Rep       Date:  2021-01-18       Impact factor: 2.316

2.  Early treatment with Resolvin E1 facilitates myocardial recovery from ischaemia in mice.

Authors:  Guizhu Liu; Qian Liu; Yujun Shen; Deping Kong; Yanjun Gong; Bo Tao; Guilin Chen; Shumin Guo; Juanjuan Li; Shengkai Zuo; Yu Yu; Huiyong Yin; Li Zhang; Bin Zhou; Colin D Funk; Jian Zhang; Ying Yu
Journal:  Br J Pharmacol       Date:  2017-10-22       Impact factor: 8.739

Review 3.  Specialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases.

Authors:  Nandini Krishnamoorthy; Raja-Elie E Abdulnour; Katherine H Walker; Braden D Engstrom; Bruce D Levy
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

4.  Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes.

Authors:  Marcelo O Freire; Jesmond Dalli; Charles N Serhan; Thomas E Van Dyke
Journal:  J Immunol       Date:  2016-12-19       Impact factor: 5.422

Review 5.  Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation.

Authors:  Melody G Duvall; Thayse R Bruggemann; Bruce D Levy
Journal:  Mol Aspects Med       Date:  2017-05-17

6.  PI3K inhibition protects mice from NAFLD by down-regulating CMKLR1 and NLRP3 in Kupffer cells.

Authors:  Wenfeng Zhang; Yan Liu; Mingbing Wu; Xiwen Zhu; Tao Wang; Kun He; Peizhi Li; Xiaoling Wu
Journal:  J Physiol Biochem       Date:  2017-09-13       Impact factor: 4.158

7.  Gαi2 Signaling Regulates Inflammasome Priming and Cytokine Production by Biasing Macrophage Phenotype Determination.

Authors:  Ali Vural; Neel R Nabar; Il-Young Hwang; Silke Sohn; Chung Park; Mikael C I Karlsson; Joe B Blumer; John H Kehrl
Journal:  J Immunol       Date:  2019-01-25       Impact factor: 5.422

8.  A model for the optimization of anti-inflammatory treatment with chemerin.

Authors:  Simao Laranjeira; Daniel Regan-Komito; Asif J Iqbal; David R Greaves; Stephen J Payne; Piotr Orlowski
Journal:  Interface Focus       Date:  2017-12-15       Impact factor: 3.906

Review 9.  Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes.

Authors:  Corneliu Sima; Bruce Paster; Thomas E Van Dyke
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 10.  A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2021-06-26       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.